
|Articles|May 1, 2002
Supplements and Featured Publications
- Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care
- Volume 8
- Issue 7 Suppl
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population
Advertisement
Articles in this issue
over 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
5 Things to Know as Flu Season Begins
3
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
4
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
5









































